Antipsychotic medication for childhood-onset schizophrenia - sprookjes - yvandenbroek - TriplyDB

Antipsychotic medication for childhood-onset schizophrenia

Antipsychotic medication for childhood-onset schizophrenia

http://www.wikidata.org/entity/Q24243972

about

Atypical antipsychotics for psychosis in adolescents Psychological interventions for psychosis in adolescents Atypical antipsychotics for psychosis in adolescents Typical antipsychotics for psychosis in adolescents Interventions for psychosis in adolescents Efficacy and safety of pharmacological and psychological interventions for the treatment of psychosis and schizophrenia in children, adolescents and young adults: a systematic review and meta-analysis Antipsychotic treatment for children and adolescents with schizophrenia spectrum disorders: protocol for a network meta-analysis of randomised trials.

P2860

Q24197475-DF47E94A-3475-4A6A-A01D-227991755F4C Q24203937-0B7A011D-7512-4537-BF57-5A20E6835D7C Q24203954-AA758714-DC29-4C45-9201-0C51BA380095 Q24203964-994C332D-FBA2-4692-9AAC-5CA3F86A1B5F Q24246919-AF7BF861-1D39-4FD4-B68B-D8C08EA1E062 Q28650054-77639A8E-4621-4DCE-98E3-CEB680F4A0D1 Q34327978-F2A548A8-C247-4A32-B881-1B58615DC990

P2860

Antipsychotic medication for childhood-onset schizophrenia

http://www.wikidata.org/entity/Q24243972

description

2007 nî lūn-bûn

@nan

2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Antipsychotic medication for childhood-onset schizophrenia

@ast

Antipsychotic medication for childhood-onset schizophrenia

@en

Antipsychotic medication for childhood-onset schizophrenia

@en-gb

Antipsychotic medication for childhood-onset schizophrenia

@nl

type

label

Antipsychotic medication for childhood-onset schizophrenia

@ast

Antipsychotic medication for childhood-onset schizophrenia

@en

Antipsychotic medication for childhood-onset schizophrenia

@en-gb

Antipsychotic medication for childhood-onset schizophrenia

@nl

prefLabel

Antipsychotic medication for childhood-onset schizophrenia

@ast

Antipsychotic medication for childhood-onset schizophrenia

@en

Antipsychotic medication for childhood-onset schizophrenia

@en-gb

Antipsychotic medication for childhood-onset schizophrenia

@nl

P1433

Q24243972-D63A9B3A-2ABF-459D-B59E-216CB9FD624C

P1476

Q24243972-122F8AD3-5537-4969-9B7A-A1FD3B9AAF34

P2093

Q24243972-CDB95905-788F-4D77-A9DD-014895D9279C

Q24243972-E1028864-E955-484D-8CEC-A1F531F21931

P2860

Q24243972-128014D5-350E-4641-A290-70FDAB6B56D1

Q24243972-19142F10-A364-4FA6-8B49-6C72036173A5

Q24243972-1A824352-1844-4457-9CC2-2E3B04528F90

Q24243972-1DEC6BA9-023C-47C1-B422-092EB11598A9

Q24243972-25597481-E92B-4168-B386-81232D972620

Q24243972-256EC625-A119-4D3F-8883-7E066FB73A32

Q24243972-2C9F8F01-D02F-4E39-AFF9-FFE72C9E4835

Q24243972-32527D7B-E8D6-4377-B995-8CC27F794EF2

Q24243972-3481625E-1F88-48D5-ABF9-CDB47AF0DAE5

Q24243972-388D4A43-CF30-4ACC-8E91-F90304F8D1D5

P304

Q24243972-F5316FB5-E0A1-4FA2-A2FE-9F94A48DE19E

P31

Q24243972-2D421CA2-AB56-48F7-9CD4-B9587003D8C7

P356

Q24243972-E0EAC5FF-A492-492B-A6B2-1EDA65844D38

P433

Q24243972-9ADA7B22-42A5-4424-86F8-571285DCDE58

P50

Q24243972-577E7853-A84F-4923-B8CE-7AD684F425C9

P577

Q24243972-C3E58041-B5D5-495C-8418-8AEDC893342B

P698

Q24243972-2F36CD60-9941-4115-AB02-EDA18421C9ED

P921

Q24243972-4D8630C9-F99E-4788-97AB-61E2192E1218

P932

Q24243972-152DE3DA-D01F-4AC1-AADD-0BC89C983A96

P356

14651858.CD004027.PUB2

P1433

Cochrane Database of Systematic Reviews

P1476

Antipsychotic medication for childhood-onset schizophrenia

@en

P2093

A Kumar

http://www.w3.org/2001/XMLSchema#string

S S Datta

http://www.w3.org/2001/XMLSchema#string

P2860

Measuring inconsistency in meta-analyses

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials

Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis

Problems of nosology and psychodynamics of early infantile autism

A children's global assessment scale (CGAS)

The positive and negative syndrome scale (PANSS) for schizophrenia

A new depression scale designed to be sensitive to change

Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994.

P304

CD004027

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/14651858.CD004027.PUB2

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-07-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17636744

http://www.w3.org/2001/XMLSchema#string

P921

P932

6984668

http://www.w3.org/2001/XMLSchema#string